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Community oncology clinicians’ knowledge, beliefs, and attitudes 
regarding genomic tumor testing
Eric Anderson1, Alexandra Hinton1, Kimberly Murray1, Hayley Mandeville1, Caitlin Gutheil1, Leo Waterston1, Lee 
Lucas1, Christine Duarte1, Christian Thomas2, Susan Miesfeldt3, Petra Helbig4, Andrey Antov4, Jens Rueter4, Paul Han1
Introduction
Genomic tumor testing (GTT) is a new technology 
that promises to make cancer treatment more 
precise. However, little is known about clinicians’ 
knowledge, beliefs, and attitudes regarding GTT, 
particularly in community oncology settings. 
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Results
Fifty-nine clinicians were invited to complete surveys 
and 58 agreed to participate (98% response rate).
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Methods
58 Maine-based oncology clinicians completed a 
survey, as part of their participation in the Jackson 
Laboratory Maine Cancer Genomics Initiative (MCGI). 
The survey assessed their past and anticipated future 
testing practices, and their attitudes, confidence, and 
perceived barriers to implementing GTT.
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10.9 %
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Number (%)
Credentials
DO 5 (9%)
MD 53 (91%)
Gender
Male 29 (50%)
Female 26 (45%)
Unknown 3 (5%)
Practice Setting
Rural 18 (31%)
Small town 15 (26%)
Suburban 12 (21%)
Urban 9 (16%)
Unknown 4 (7%)
Years of Experience
1-4 1 (2%)
5-9 7 (12%)
10-19 24 (41%)
20-29 13 (22%)
30+ 10 (17%)
Unknown 3 (5%)
Practice Size
1-4 24 (41%)
5-9 12 (21%)
10+ 16 (28%)
Unknown 6 (10%)
For what % of your patients 
did/will you order GTT?
Barriers to genomic tumor testing
Attitudes towards genomic tumor testing
Conclusions
• Oncology clinicians practicing in community settings report relatively 
high current use of GTT and higher anticipated use in the future. 
• As GTT becomes more widespread, the knowledge, attitudes, and 
educational needs of community-based oncology clinicians will need 
to be understood and supported.
Confidence in using genomic tumor testing
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